Our findings that COL1A1 is highly expressed at both mRNA and protein levels in HCC, strongly correlates with disease progression, and confers significant survival disadvantage to patients with HCC ( Figure 1 and Figure 2). This evidence concerns the gene COL1A1 and hepatocellular carcinoma.